Evidence used
- No CISA KEV confirmation is currently recorded.
- Exploitation requires an existing local or physical foothold with privileges.
- EPSS is 0.33% for the current model date.
BlackTreeCVE IntelligenceUnknown · Unknown
Medium technical severity with no CISA KEV confirmation; remediate through the normal risk-based patch cycle unless local exposure raises the priority.
Debian findings are scoped to the named distribution, release and source package. An absent finding does not mean a package is unaffected.
A published vendor fix does not prove that a matching update is enabled and installable on a particular asset. Confirm the local package candidate before scheduling remediation.
| Distribution release | Source package | Vendor state | Fixed version | Evidence |
|---|---|---|---|---|
| Debian trixietrixie · source | nova | Vendor fix publishedDebian records a fixed source-package version for this release. | 2014.1-1 | Debian Security Tracker ↗Source updated 5 Oct 2026 |
| Debian bookwormbookworm · source | nova | Vendor fix publishedDebian records a fixed source-package version for this release. | 2014.1-1 | Debian Security Tracker ↗Source updated 5 Oct 2026 |
| Debian forkyforky · source | nova | Vendor fix publishedDebian records a fixed source-package version for this release. | 2014.1-1 | Debian Security Tracker ↗Source updated 5 Oct 2026 |
| Debian sidsid · source | nova | Vendor fix publishedDebian records a fixed source-package version for this release. | 2014.1-1 | Debian Security Tracker ↗Source updated 5 Oct 2026 |
These OSV and GitHub advisory ranges apply only to the named package and ecosystem. A listed fixed version is not a universal product patch or proof that an update is installed.
| Ecosystem and package | Affected range | First fixed version | Evidence |
|---|---|---|---|
| pipnova | < 15.0.0.0b1 | 15.0.0.0b1 | GitHub advisory ↗github reviewed aggregator · 26 Nov 2024 |
Medium technical severity with no CISA KEV confirmation; remediate through the normal risk-based patch cycle unless local exposure raises the priority.
Fix not verifiedOpenStack Compute (nova) Icehouse, Juno and Havana when live migration fails allows local users to access VM volumes that they would normally not have permissions for.
OpenStack Compute (nova) Icehouse, Juno and Havana when live migration fails allows local users to access VM volumes that they would normally not have permissions for.
The product does not restrict or incorrectly restricts access to a resource from an unauthorized actor.
An attacker operating through local access may attempt exploitation with low privileges. If successful, the issue may cause the confidentiality, integrity or availability impact described by the vendor.
OpenStack Compute (nova) Icehouse, Juno and Havana when live migration fails allows local users to access VM volumes that they would normally not have permissions for.
The product does not restrict or incorrectly restricts access to a resource from an unauthorized actor.
An attacker operating through local access may attempt exploitation with low privileges. If successful, the issue may cause the confidentiality, integrity or availability impact described by the vendor.
CVSS severity, EPSS forecast probability, public exploit material and CISA-confirmed exploitation are separate signals.
No CISA KEV match was present at the last successful refresh. This means no confirmation from that source, not proof of no exploitation.
No exploit-tagged reference or CISA SSVC proof-of-concept state is currently recorded. Research may still exist outside the structured feeds.
CWE-284: Improper Access Control. The product does not restrict or incorrectly restricts access to a resource from an unauthorized actor.
CVSS:3.0/AV:L/AC:H/PR:L/UI:N/S:U/C:H/I:N/A:NCommon Vulnerability Scoring System 3.0: the compact vector below is decoded into plain language.
Operational remediation based on structured source evidence.
Published 9 Aug 2017 · Last source change 6 Aug 2024, 05:24 UTC · CWE-284 · Improper Access Control
Missing structured fields: affected product. Missing data is not evidence of low risk; review the primary advisory.